--- title: FidoCure blog (7) description: Read the latest in veterinary oncology research and FidoCure® scientific and clinical updates. (7) --- [![FidoCure](https://blog.fidocure.com/hs-fs/hubfs/fidocure_logo.png?width=296&height=68&name=fidocure_logo.png "FidoCure")](https://www.fidocure.com/) - [Veterinarians](https://fidocure.com/for-veterinarians/) - [Portal Login](https://dvm.fidocure.com/) - [Veterinary Blog](https://blog.fidocure.com/fidocure-blog/tag/vet) - [Case Studies](https://blog.fidocure.com/fidocure-blog/tag/case-studies) - [Webinars](https://blog.fidocure.com/fidocure-blog/tag/webinars) - [Pet Parents](https://fidocure.com/pet-parents/) - [About Us](https://fidocure.com/about-us/) - [How it works](https://fidocure.com/how-it-works/) - [Find a Clinic](https://fidocure.com/find-a-clinic/) - [Contact Us](https://fidocure.com/contact-us/) # FidoCure Veterinary Team Blog ### Read the latest in veterinary oncology research and FidoCure scientific and clinical updates from our team of experts and advisors Select Category Case Studies Press Vet Webinars This is a search field with an auto-suggest feature attached. - There are no suggestions because the search field is empty. ![](https://blog.fidocure.com/hubfs/_(600%20%C3%97%20400%20px)%20(5).png) ### [Fireside Chat with Dr. Len Lichtenfeld - Former Deputy Chief Medical Officer of American Cancer Society](https://blog.fidocure.com/fidocure-blog/interview-with-dr.-len-lichtenfeld-former-chief-medical-officer-of-american-cancer-society) ###### Exclusive fireside chat with a distinguished trio of cancer experts: Dr. Len Lichtenfeld former Deputy Chief Medical Officer for the American Cancer Society (and FidoCure Scientific Advisory Board Member) with Dr. Gerry Post, Chief Medical Officer, FidoCure and Christina Lopes, CEO, FidoCure. ###### Hear first-hand about their 8-year journey together in the fight against cancer on both ends of the leash. [Read More](https://blog.fidocure.com/fidocure-blog/interview-with-dr.-len-lichtenfeld-former-chief-medical-officer-of-american-cancer-society) ![](https://blog.fidocure.com/hubfs/Cancer%20does%20not%20have%20to%20be%20a%20death%20sentence.%20(4).png) ### [Cancer Does Not Have to Be a Death Sentence](https://blog.fidocure.com/fidocure-blog/cancer-does-not-have-to-be-a-death-sentence)   [Read More](https://blog.fidocure.com/fidocure-blog/cancer-does-not-have-to-be-a-death-sentence) ### [The DNA from dog tumors may hold the secret to better human cancer drug](https://blog.fidocure.com/fidocure-blog/the-dna-from-dog-tumors-may-hold-the-secret-to-better-human-cancer-drug) ![stat-plus-logo.svg](https://blog.fidocure.com/hs-fs/hubfs/stat-plus-logo.svg.png?width=150&height=33&name=stat-plus-logo.svg.png) [Read More](https://blog.fidocure.com/fidocure-blog/the-dna-from-dog-tumors-may-hold-the-secret-to-better-human-cancer-drug) ![](https://blog.fidocure.com/hubfs/iStock-164853650%20(1).jpg) ### [5 Ways FidoCure Can Expand Your Veterinary Practice](https://blog.fidocure.com/fidocure-blog/5ways) Canine cancer is a heartbreaking diagnosis that affects millions of beloved pets worldwide. In fact, it’s one of the biggest unmet needs in veterinary medicine. As advancements in our field continue to evolve, FidoCure emerges as a groundbreaking solution, offering a revolutionary approach to treating canine cancer. By harnessing the power of genomic testing, FidoCure provides targeted therapies that are transforming the landscape of canine cancer care. [Read More](https://blog.fidocure.com/fidocure-blog/5ways) ![](https://blog.fidocure.com/hubfs/ardent.png) ### [Ardent and FidoCure Announce Groundbreaking Partnership](https://blog.fidocure.com/fidocure-blog/ardent-and-fidocure-announce-groundbreaking-partnership-to-increase-access-to-precision-medicine-treatments-for-pet-cancer) FOR IMMEDIATE RELEASE [Read More](https://blog.fidocure.com/fidocure-blog/ardent-and-fidocure-announce-groundbreaking-partnership-to-increase-access-to-precision-medicine-treatments-for-pet-cancer) ![](https://blog.fidocure.com/hubfs/NErhart.png) ### [Great Danes to Grandads: Comparative Cancer and Aging Research](https://blog.fidocure.com/fidocure-blog/great-danes-to-grandads-comparative-cancer-and-aging-research) Dr. Ehrhart shares insight from her current work in comparative aging research and highlights its intersection with cancer and musculoskeletal research in veterinary medicine. [Read More](https://blog.fidocure.com/fidocure-blog/great-danes-to-grandads-comparative-cancer-and-aging-research) ![](https://blog.fidocure.com/hubfs/sZhao.png) ### [What Every Veterinary Oncologist Needs to Know About Cancer Genomics](https://blog.fidocure.com/fidocure-blog/what-every-veterinary-oncologist-needs-to-know-about-cancer-genomics) Genomics is fast becoming an essential part of veterinary oncology. It touches upon all aspects of practice, from diagnostics to therapeutics. Genetic information can be incredibly useful in terms of making a more accurate diagnosis or making a more precise prognosis, or even determining what therapy to use or what order to use different therapies. [Read More](https://blog.fidocure.com/fidocure-blog/what-every-veterinary-oncologist-needs-to-know-about-cancer-genomics) ![](https://blog.fidocure.com/hubfs/NMauldin.png) ### [The Path Ahead for Combination Therapy Approaches to Canine Cancer Treatment](https://blog.fidocure.com/fidocure-blog/the-path-ahead-for-combination-therapy-approaches-to-canine-cancer-treatment) We welcomed **Dr. Neal Mauldin, Chief Medical Officer, PetCure Oncology **to our webinar series. He is one of the **only triple-boarded veterinarians**, certified in the field of internal medicine, medical oncology and radiation oncology. [Read More](https://blog.fidocure.com/fidocure-blog/the-path-ahead-for-combination-therapy-approaches-to-canine-cancer-treatment) ![dna helix](https://blog.fidocure.com/hubfs/iStock-1328132549-1.jpg) ### [How Genomic Testing Is Revolutionizing Canine Cancer Treatment](https://blog.fidocure.com/fidocure-blog/how-genomic-testing-is-revolutionizing-canine-cancer-treatment) #### Cancer is one of the biggest unmet needs in the veterinary world, despite the fact that canine cancer research shares a great deal of overlap with human oncology. Genomic testing and targeted therapies have been used for years in human cancer treatment, so it’s not surprising that recent advancements in genomic testing have proven valuable in the field of canine cancer research and treatment. FidoCure, a leading pioneer in this field, is transforming the way veterinarians approach cancer treatment for our beloved canine companions. In this blog, we will explore the cutting-edge benefits of genomic testing and how FidoCure is revolutionizing canine cancer treatment while also providing much-needed support and hope for families. [Read More](https://blog.fidocure.com/fidocure-blog/how-genomic-testing-is-revolutionizing-canine-cancer-treatment) ![Man comforting dog](https://blog.fidocure.com/hubfs/iStock-1242984893.jpg) ### [Delivering Difficult News: How to Talk to Pet Parents About Canine Cancer](https://blog.fidocure.com/fidocure-blog/delivering-difficult-news-how-to-talk-to-pet-parents-about-canine-cancer) #### As veterinarians, our work involves a wide range of emotions. We may experience the joy of treating a sick pet and seeing them recover, but we may also have to deliver the devastating news of a cancer diagnosis. It can be difficult to break such news to pet  parents who have a strong emotional bond with their dogs. However, as veterinary healthcare providers, it is our responsibility to help our clients through these tough times. [Read More](https://blog.fidocure.com/fidocure-blog/delivering-difficult-news-how-to-talk-to-pet-parents-about-canine-cancer) [5](https://blog.fidocure.com/fidocure-blog/page/5) [6](https://blog.fidocure.com/fidocure-blog/page/6) [7](https://blog.fidocure.com/fidocure-blog/page/7) [8](https://blog.fidocure.com/fidocure-blog/page/8) [9](https://blog.fidocure.com/fidocure-blog/page/9) ![fc_portal_logo_bw](https://blog.fidocure.com/hubfs/fc_portal_logo_bw.svg) - [How it Works](https://fidocure.com/how-it-works/) - [FAQ](https://fidocure.com/faq/) - [Contact Us](https://fidocurestg.wpengine.com/contact-us/) - [For Vets](https://fidocure.com/for-veterinarians/) - [About Us](https://fidocure.com/about-us/) - [Terms of Service](https://fidocure.com/terms-of-service/) - [Blog](https://blog.fidocure.com/fidocure-blog) - [Careers](https://fidocure.com/careers/) - [Privacy Policy](https://fidocure.com/privacy-policy/) - - - - **FidoCure® is an advanced cancer-care service for dogs, developed by One Health Company**. DISCLAIMER: All patients are enrolled in FidoCure® by a veterinarian with a valid veterinarian-client-patient relationship (VCPR). We use best efforts to inform the veterinarian on available targeted therapy options for patients. FidoCure® does not prescribe therapy. The targeted therapies that veterinarians may prescribe and order from compounding pharmacies, after receiving genetic test results from FidoCure®, may constitute extra-label uses of those drugs. FidoCure® makes no claims that every patient will have genetic test results that lead to targeted therapy options. FidoCure® makes no claims or guarantees about the effectiveness of the diagnostic and targeted therapy selected by the veterinarian for an individual patient. Like most cancer care approaches, the services provided by FidoCure® are not a guarantee of a cure. FidoCure® is not a pharmacy and does not supply drugs directly. By ordering any medication via one of our pharmacy partners, you agree that the pharmacy, not FidoCure®, is solely responsible and liable for any and all issues relating to the preparation, dispensation and fulfillment of the medication. The lifetime offer is subject to the commercially reasonable availability of any medication(s) and/or active pharmaceutical ingredient(s) necessary for the selected therapy.  © Copyright 2018-2026 One Health Company, All rights reserved